Interactive Session:
39. Challenging HIV Cases
Friday, October 21, 2011: 10:45 AM-12:15 PM
Room: Grand Ballroom (East-West)

Learning Objectives:

At the conclusion of this session, participants will be able to apply principles of HIV medicine to challenging clinical cases in HIV.

Target Audience: Scientists, Researchers, Pharmacists, Nurses, Microbiologists, Lab Personnel, Infectious Diseases Physicians, HIV Clinicians, Clinicians

Tracks: HIV

Interactive Moderators:  Nesli Basgoz, MD, FIDSA, Massachusetts General Hospital , Paul Sax, MD, FIDSA, Brigham and Women's Hospital and Kimberly Smith, MD, MPH, Rush-Presbyterian-St. Luke's Medical Center

Presentations:

10:45 AM
150
Interactive Panelist
Oluwatoyin Adeyemi, MD

11:05 AM
151
Interactive Panelist
David Alain Wohl, MD

CME Credits: Maximum of 1.5 hours of Category 1 credit possible

ACPE Credits: ACPE 1.5 application-based contact hours (0.15 CEU) of Pharmacy CE

ACPE Number: 0461-9999-11-138-L02-P

Disclosures:

N. Basgoz, Forrest Laboratories: Shareholder, Stocks/Bonds and Options revenues

P. Sax, Abbott: Consultant, Consulting fee
BMS: Investigator and Scientific Advisor, Consulting fee and Research grant
Gilead: Investigator and Scientific Advisor, Consulting fee and Research grant
Merck: Investigator and Scientific Advisor, Consulting fee and Research grant
GSK: Consultant and Investigator, Consulting fee and Research grant
Tibotec: Investigator and Scientific Advisor, Consulting fee and Grant recipient

K. Smith, Bristol Myer Squibb: Scientific Advisor, Consulting fee
glaxosmithkline: Scientific Advisor, Consulting fee
gilead: Scientific Advisor, Consulting fee
merck: Scientific Advisor, Consulting fee
viiv: Scientific Advisor, Consulting fee
tibotec: Scientific Advisor, Consulting fee

O. Adeyemi, Tibotec: Investigator, Research support

D. A. Wohl, Merck: Grant Investigator and Research Contractor, Research support
GSK: Grant Investigator and Research Contractor, Research support
Tibotec: Consultant, Consulting fee
Gilead: Consultant, Consulting fee
BMS: Consultant, Consulting fee
Abbott: Consultant, Consulting fee

See more of: Interactive Session

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.